Tangible Property and Exclusive Patent License Agreement Sample Contracts

WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH and YUMANITY THERAPEUTICS, INC. And YUMANITY HOLDINGS LLC TANGIBLE PROPERTY AND EXCLUSIVE PATENT LICENSE AGREEMENT Dated February 4, 2016

Tangible Property and Exclusive Patent License Agreement • September 23rd, 2020 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Tangible Property and Exclusive Patent License Agreement
• Filed
  September 23rd, 2020
• Company
  Proteostasis Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

This Agreement, effective as of February 4, 2016 (the “EFFECTIVE DATE”), is between the Whitehead Institute for Biomedical Research (“WHITEHEAD”), a Delaware corporation, with a principal office at Nine Cambridge Center, Cambridge, MA 02142, and Yumanity Therapeutics, Inc. (“COMPANY”), a Delaware corporation, and solely for the purpose of Section 4.1(i) Yumanity Holdings LLC (“PARENT”), a Delaware limited liability company, both with a principal office at 790 Memorial Drive, Suite 2C, Cambridge, MA 02139. WHITEHEAD and COMPANY are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.